Zileuton (Prasco, LLC)


Welcome to the PulseAid listing for the Zileuton drug offered from Prasco, LLC. This 5-Lipoxygenase Inhibitor [EPC],5-Lipoxygenase Inhibitors [MoA],Decreased Leukotriene Production [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Prasco, LLC
NON-PROPRIETARY NAME: Zileuton
SUBSTANCE NAME: ZILEUTON
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: 5-Lipoxygenase Inhibitor [EPC],5-Lipoxygenase Inhibitors [MoA],Decreased Leukotriene Production [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2017-03-29
END MARKETING DATE: 0000-00-00


Zileuton HUMAN PRESCRIPTION DRUG Details:

Item DescriptionZileuton from Prasco, LLC
LABELER NAME: Prasco, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 600(mg/1)
START MARKETING DATE: 2017-03-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66993-485_cac42cc3-792c-4b76-a398-c4961fea3018
PRODUCT NDC: 66993-485
APPLICATION NUMBER: NDA022052

Other ZILEUTON Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Chiesi USA, Inc.ZYFLO
Prasco, LLCZileuton
Rising Pharmaceuticals, Inc.Zileuton